Research

Hormonal

Six months of once-weekly GLP-1 analogue (semaglutide) therapy restores natural killer (NK) cell effector function (cytotoxicity and cytokine production) in people with obesity, independent of weight loss.

For people with obesity, GLP-1 therapy (like semaglutide) may strengthen the immune system's ability to fight viruses and cancer, independent of how much weight is lost. This suggests benefits beyond just metabolic health.

ModerateSupportsMEDIUM confidence
These data demonstrate that PWO who received GLP-1 therapy have improved NK cell function, as measured by cytotoxicity and interferon-γ/granzyme B production... Finally, it shows that the reported improvements in NK cell function appear to be independent of weight loss.
Conor De Barra et al. · Obesity · 2023

Why this rating

Small cohort (n=20), single-arm pre-post design without a non-obese control group for the post-treatment comparison, though it includes pre-treatment baseline comparisons.

Source

Glucagon‐like peptide‐1 therapy in people with obesity restores natural killer cell metabolism and effector function

Conor De Barra et al. · Obesity · 2023

DOI 10.1002/oby.23772

cohort · n=20Cited 43×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →